Wells Fargo & Company Beyond Spring Inc. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding BYSI
# of Institutions
22Shares Held
5.77MCall Options Held
53.2KPut Options Held
2.5K-
Decheng Capital LLC Menlo Park, CA4.96MShares$12.7 Million3.65% of portfolio
-
Citigroup Inc454KShares$1.17 Million0.0% of portfolio
-
Black Rock Inc. New York, NY215KShares$553,4620.0% of portfolio
-
Tanaka Capital Management Inc New York, NY29.5KShares$75,7450.17% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$62,6250.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $100M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...